Rebiopsy and Acquired Mutations Following Progression in Non-Small Cell Lung Cancer

Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss the need to perform a second biopsy to check for the loss or acquisition of mutations in non-small cell lung cancer following progression.

For more from this conversation: http://www.onclive.com/peer-ex....change/nsclc-advance

• Kategorie